HHI: Health House International Limited - Summary | Jitta

Health House International Limited

AUS:HHI

Notice
Stock data is unavailable or the company’s delisted.
Price
AU$0.01
Loss Chance
58.0%
1.95JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (28)
Recent Business Performance (64)
Financial Strength (27)
Return to Shareholders (13)
Competitive Advantage (34)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Operating MarginInconsistent
Recent Business PerformanceEarning decline 82.90% in the last year
Key Stats
Jitta Score
Jitta Line
1.95
100.00%
1.46
76.75%
1.46
76.75%
3.35
238.35%
3.85
169.69%
4.14
667.98%
COMPANY DESCRIPTION
Health House International Limited distributes medicinal cannabis products in Australasia, the United Kingdom, and Europe. It supplies a range of pharmaceutical products to pharmacies, hospitals, government departments, ambulance workers, and other wholesalers. The company was formerly known as Health House Holdings Limited and changed its name to Health House International Limited in March 2021. Health House International Limited was incorporated in 2011 and is based in Perth, Australia. As of May 16, 2023, Health House International Limited operates as a subsidiary of Creso Pharma Limited.